JOINT FILING AGREEMENTJoint Filing Agreement • June 30th, 2017 • SC Fundamental Value Fund, L.P. • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including amendments thereto) with respect to the Common Stock of Aviragen Therapeutics, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, hereby execute this Agreement this 30th day of June, 2017.
